UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹992 Cr | ₹738 Cr | ₹640 Cr | ₹552 Cr | ₹506 Cr |
What is the latest Total Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹992 Cr |
| Mar2024 | ₹738 Cr |
| Mar2023 | ₹640 Cr |
| Mar2022 | ₹552 Cr |
| Mar2021 | ₹506 Cr |
How is Total Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹992 Cr | 34.49 | |
| Mar2024 | ₹738 Cr | 15.32 | |
| Mar2023 | ₹640 Cr | 15.84 | |
| Mar2022 | ₹552 Cr | 9.17 | |
| Mar2021 | ₹506 Cr | - | |
Compare Total Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹1,998.0 Cr | -9.3% | -20.1% | -57.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -9.3% |
-20.1% |
-57.9% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses